182 related articles for article (PubMed ID: 18511017)
1. The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma.
Wright JD; Seshan VE; Shah M; Schiff PB; Burke WM; Cohen CJ; Herzog TJ
Am J Obstet Gynecol; 2008 Nov; 199(5):536.e1-8. PubMed ID: 18511017
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
Nemani D; Mitra N; Guo M; Lin L
Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
[TBL] [Abstract][Full Text] [Related]
3. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
[TBL] [Abstract][Full Text] [Related]
5. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
Clayton Smith D; Kenneth Macdonald O; Gaffney DK
Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
[TBL] [Abstract][Full Text] [Related]
6. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
Li Y; Ren H; Wang J
BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
[TBL] [Abstract][Full Text] [Related]
7. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
[TBL] [Abstract][Full Text] [Related]
8. Role of radiotherapy treatment of uterine sarcoma.
Sampath S; Gaffney DK
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation.
Wright JD; Fiorelli J; Kansler AL; Burke WM; Schiff PB; Cohen CJ; Herzog TJ
Am J Obstet Gynecol; 2009 Apr; 200(4):419.e1-7. PubMed ID: 19136095
[TBL] [Abstract][Full Text] [Related]
10. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome and natural history of uterine adenosarcomas.
Arend R; Bagaria M; Lewin SN; Sun X; Deutsch I; Burke WM; Herzog TJ; Wright JD
Gynecol Oncol; 2010 Nov; 119(2):305-8. PubMed ID: 20688363
[TBL] [Abstract][Full Text] [Related]
12. A comparison between different postoperative treatment modalities of uterine carcinosarcoma.
Menczer J; Levy T; Piura B; Chetrit A; Altaras M; Meirovitz M; Glezerman M; Fishman A
Gynecol Oncol; 2005 Apr; 97(1):166-70. PubMed ID: 15790453
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
[TBL] [Abstract][Full Text] [Related]
15. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
[TBL] [Abstract][Full Text] [Related]
16. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
[TBL] [Abstract][Full Text] [Related]
17. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy.
Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
Le T
Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
Sorbe B; Johansson B
Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).
Cha J; Kim YS; Park W; Kim HJ; Kim JY; Kim JH; Kim J; Yoon WS; Kim JW; Kim YB
J Gynecol Oncol; 2016 Nov; 27(6):e58. PubMed ID: 27550404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
